Exenatide Injection — Class II drug recall D-0868-2026
Ongoing recall by Amneal Pharmaceuticals of New York, LLC, reported 2026-09-30, distributed nationwide. Defective Delivery System: Possibility of no medication in the prefilled pen.
| Recall number | D-0868-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY, United States |
| Recall initiated | 2026-08-28 |
| Classified | 2026-09-22 |
| Reported by FDA | 2026-09-30 |
| Distributed | Nationwide (US) |
| Quantity | 5,694 pens |
| NDC | 70121-1685, 70121-1685-01, 70121-1686, 70121-1686-01 |
| Lot numbers | AP250095A |
| Expiration dates | 2027-02-28 |
Product
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
Reason for recall
Defective Delivery System: Possibility of no medication in the prefilled pen.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0868-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-06. Not affiliated with or endorsed by FDA. Not medical or legal advice.